{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:11:43Z","timestamp":1793913103052,"version":"4.8.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s10549-020-05556-y","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T08:02:24Z","timestamp":1581321744000},"page":"471-479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Male breast cancer: a closer look at patient and tumor characteristics and factors that affect survival using the National Cancer Database"],"prefix":"10.1007","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6362-9434","authenticated-orcid":false,"given":"Samuel","family":"Sarmiento","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McColl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Musavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiz","family":"Gani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph K.","family":"Canner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanmeng","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalampos","family":"Siotos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"issue":"10","key":"5556_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nrc3806","volume":"14","author":"L Ottini","year":"2014","unstructured":"Ottini L (2014) Male breast cancer: a rare disease that might uncover underlying pathways of breast cancer. Nat Rev Cancer 14(10):643\u2013644. https:\/\/doi.org\/10.1038\/nrc3806","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"5556_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10549-008-0053-y","volume":"115","author":"V Speirs","year":"2009","unstructured":"Speirs V, Shaaban AM (2009) The rising incidence of male breast cancer. Breast Cancer Res Treat 115(2):429\u2013430. https:\/\/doi.org\/10.1007\/s10549-008-0053-y","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"5556_CR3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10549-007-9882-3","volume":"112","author":"A Stang","year":"2008","unstructured":"Stang A, Thomssen C (2008) Decline in breast cancer incidence in the United States: What about male breast cancer? Breast Cancer Res Treat 112(3):595\u2013596. https:\/\/doi.org\/10.1007\/s10549-007-9882-3","journal-title":"Breast Cancer Res Treat"},{"key":"5556_CR4","volume-title":"Current surgical therapy","author":"S Sarmiento","year":"2019","unstructured":"Sarmiento S, McColl M, Habibi M (2019) The management of male breast cancer. In: Cameron JL (ed) Current surgical therapy, 13th edn. Elsevier, Philadelphia","edition":"13"},{"issue":"8696","key":"5556_CR5","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/0140-6736(90)91075-L","volume":"335","author":"IS Fentiman","year":"1990","unstructured":"Fentiman IS, Tirelli U, Monfardini S et al (1990) Cancer in the elderly: why so badly treated? Lancet 335(8696):1020\u20131022","journal-title":"Lancet"},{"issue":"suppl 8","key":"5556_CR6","doi-asserted-by":"publisher","first-page":"viii75","DOI":"10.1093\/annonc\/mdt316","volume":"24","author":"P Rizzolo","year":"2013","unstructured":"Rizzolo P, Silvestri V, Tommasi S et al (2013) Male breast cancer: genetics, epigenetics, and ethical aspects. Ann Oncol 24(suppl 8):viii75\u2013viii82. https:\/\/doi.org\/10.1093\/annonc\/mdt316","journal-title":"Ann Oncol"},{"issue":"12","key":"5556_CR7","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1200\/JCO.2009.25.5729","volume":"28","author":"LA Korde","year":"2010","unstructured":"Korde LA, Zujewski JA, Kamin L et al (2010) Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol 28(12):2114\u20132122. https:\/\/doi.org\/10.1200\/JCO.2009.25.5729","journal-title":"J Clin Oncol"},{"key":"5556_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.breast.2015.12.001","author":"M Henriques Abreu","year":"2016","unstructured":"Henriques Abreu M, Emia Afonso N, Henriques Abreu P et al (2016) Male breast cancer: looking for better prognostic subgroups. Breast. https:\/\/doi.org\/10.1016\/j.breast.2015.12.001","journal-title":"Breast"},{"issue":"33","key":"5556_CR9","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1200\/JCO.2011.36.8902","volume":"29","author":"H Miao","year":"2011","unstructured":"Miao H, Verkooijen HM, Chia K-S et al (2011) Incidence and outcome of male breast cancer: an international population-based study. J Clin Oncol 29(33):4381\u20134386. https:\/\/doi.org\/10.1200\/JCO.2011.36.8902","journal-title":"J Clin Oncol"},{"issue":"1","key":"5556_CR10","doi-asserted-by":"publisher","first-page":"aqw207","DOI":"10.1093\/ajcp\/aqw207","volume":"147","author":"KM Serdy","year":"2017","unstructured":"Serdy KM, Leone JP, Dabbs DJ, Bhargava R (2017) Male breast cancer. Am J Clin Pathol 147(1):aqw207. https:\/\/doi.org\/10.1093\/ajcp\/aqw207","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"5556_CR11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1001\/archsurg.139.10.1079","volume":"139","author":"MB El-Tamer","year":"2004","unstructured":"El-Tamer MB, Komenaka IK, Troxel A et al (2004) Men with breast cancer have better disease-specific survival than women. Arch Surg 139(10):1079. https:\/\/doi.org\/10.1001\/archsurg.139.10.1079","journal-title":"Arch Surg"},{"issue":"5","key":"5556_CR12","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.clbc.2014.02.008","volume":"14","author":"M Iorfida","year":"2014","unstructured":"Iorfida M, Bagnardi V, Rotmensz N et al (2014) Outcome of male breast cancer: a matched single-institution series. Clin Breast Cancer 14(5):371\u2013377. https:\/\/doi.org\/10.1016\/j.clbc.2014.02.008","journal-title":"Clin Breast Cancer"},{"key":"5556_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.breast.2013.02.005","volume":"22","author":"X-F Yu","year":"2013","unstructured":"Yu X-F, Feng W-L, Miao L-L, Chen B, Yang H-J, Yang H-J (2013) The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study. The Breast 22:824\u2013827. https:\/\/doi.org\/10.1016\/j.breast.2013.02.005","journal-title":"The Breast"},{"issue":"10","key":"5556_CR14","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1245\/s10434-016-5486-7","volume":"23","author":"AC Polverini","year":"2016","unstructured":"Polverini AC, Nelson RA, Marcinkowski E et al (2016) Time to treatment: measuring quality breast cancer care. Ann Surg Oncol 23(10):3392\u20133402. https:\/\/doi.org\/10.1245\/s10434-016-5486-7","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"5556_CR15","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1245\/s10434-012-2479-z","volume":"19","author":"JM Greif","year":"2012","unstructured":"Greif JM, Pezzi CM, Klimberg VS, Bailey L, Zuraek M (2012) Gender differences in breast cancer: analysis of 13,000 breast cancers in men from the national cancer data base. Ann Surg Oncol 19(10):3199\u20133204. https:\/\/doi.org\/10.1245\/s10434-012-2479-z","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"5556_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cncr.20312","volume":"101","author":"SH Giordano","year":"2004","unstructured":"Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN (2004) Breast carcinoma in men. Cancer 101(1):51\u201357. https:\/\/doi.org\/10.1002\/cncr.20312","journal-title":"Cancer"},{"issue":"4","key":"5556_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/J.IJROBP.2013.07.016","volume":"87","author":"EC Fields","year":"2013","unstructured":"Fields EC, DeWitt P, Fisher CM, Rabinovitch R (2013) Management of male breast cancer in the united states: a surveillance, epidemiology and end results analysis. Int J Radiat Oncol 87(4):747\u2013752. https:\/\/doi.org\/10.1016\/J.IJROBP.2013.07.016","journal-title":"Int J Radiat Oncol"},{"key":"5556_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/J.CRITREVONC.2017.03.013","volume":"113","author":"A Losurdo","year":"2017","unstructured":"Losurdo A, Rota S, Gullo G et al (2017) Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: a review of the literature. Crit Rev Oncol Hematol 113:283\u2013291. https:\/\/doi.org\/10.1016\/J.CRITREVONC.2017.03.013","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"5556_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/J.CLBC.2013.04.003","volume":"13","author":"DK Patten","year":"2013","unstructured":"Patten DK, Sharifi LK, Fazel M (2013) New approaches in the management of male breast cancer. Clin Breast Cancer 13(5):309\u2013314. https:\/\/doi.org\/10.1016\/J.CLBC.2013.04.003","journal-title":"Clin Breast Cancer"},{"issue":"9472","key":"5556_CR20","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/S0140-6736(05)66524-5","volume":"365","author":"S Chia","year":"2005","unstructured":"Chia S, Bryce C, Gelmon K (2005) The 2000 EBCTCG overview: a widening gap. Lancet 365(9472):1665\u20131666. https:\/\/doi.org\/10.1016\/S0140-6736(05)66524-5","journal-title":"Lancet"},{"issue":"14","key":"5556_CR21","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1056\/NEJM199710023371402","volume":"337","author":"J Ragaz","year":"1997","unstructured":"Ragaz J, Jackson SM, Le N et al (1997) Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337(14):956\u2013962. https:\/\/doi.org\/10.1056\/NEJM199710023371402","journal-title":"N Engl J Med"},{"issue":"14","key":"5556_CR22","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1056\/NEJM199710023371401","volume":"337","author":"M Overgaard","year":"1997","unstructured":"Overgaard M, Hansen PS, Overgaard J et al (1997) Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337(14):949\u2013955. https:\/\/doi.org\/10.1056\/NEJM199710023371401","journal-title":"N Engl J Med"},{"issue":"8784","key":"5556_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0140-6736(92)90139-T","volume":"339","author":"Early Breast Cancer Trialists\u2019 Collaborative Group","year":"1992","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (1992) Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 339(8784):1\u201315. https:\/\/doi.org\/10.1016\/0140-6736(92)90139-T","journal-title":"Lancet"},{"issue":"10","key":"5556_CR24","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.1245\/s10434-018-6663-7","volume":"25","author":"B Jabo","year":"2018","unstructured":"Jabo B, Lin AC, Aljehani MA et al (2018) Impact of breast reconstruction on time to definitive surgical treatment, adjuvant therapy, and breast cancer outcomes. Ann Surg Oncol 25(10):3096\u20133105. https:\/\/doi.org\/10.1245\/s10434-018-6663-7","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"5556_CR25","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ijc.31411","volume":"143","author":"L Eriksson","year":"2018","unstructured":"Eriksson L, Bergh J, Humphreys K, W\u00e4rnberg F, T\u00f6rnberg S, Czene K (2018) Time from breast cancer diagnosis to therapeutic surgery and breast cancer prognosis: a population-based cohort study. Int J Cancer 143(5):1093\u20131104. https:\/\/doi.org\/10.1002\/ijc.31411","journal-title":"Int J Cancer"},{"issue":"4","key":"5556_CR26","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/tbj.12758","volume":"23","author":"SA Mansfield","year":"2017","unstructured":"Mansfield SA, Abdel-Rasoul M, Terando AM, Agnese DM (2017) Timing of breast cancer surgery-how much does it matter? Breast J 23(4):444\u2013451. https:\/\/doi.org\/10.1111\/tbj.12758","journal-title":"Breast J"},{"issue":"3","key":"5556_CR27","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1001\/jamaoncol.2015.4508","volume":"2","author":"RJ Bleicher","year":"2016","unstructured":"Bleicher RJ, Ruth K, Sigurdson ER et al (2016) Time to surgery and breast cancer survival in the United States. JAMA Oncol 2(3):330. https:\/\/doi.org\/10.1001\/jamaoncol.2015.4508","journal-title":"JAMA Oncol"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-020-05556-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-020-05556-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:12:46Z","timestamp":1612915966000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-020-05556-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["5556"],"URL":"https:\/\/doi.org\/10.1007\/s10549-020-05556-y","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"16 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The National Cancer Data Base (NCDB) is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC\u2019s NCDB and the hospitals participating in the CoC NCDB are the source of the de-identified data used in this report. They have not verified the data and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"De-identified data from the National Cancer Data Base (NCDB; see title page); IRB review not required. This study conforms to the Declaration of Helsinki ethical principles for medical research.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}